Peptide hormone processing in tumours: biogenetic and diagnostic implications

Area of Science:

• Endocrinology and Molecular Biology
• Biochemistry of Peptide Hormones
• Tumor Biology

Background:

• Peptide hormone biogenesis is increasingly understood through gene, mRNA, and prohormone structure elucidation.
• Prohormone processing enzymes and their diverse roles in generating bioactive peptides are actively being researched.
• Prohormones exhibit varied structures and are classified into families based on sequence homology.

Purpose of the Study:

• To explore the significance of cell-specific prohormone processing patterns in peptide hormone synthesis within tumors.
• To investigate the clinical implications of attenuated peptide translation and post-translational processing in common carcinomas.
• To evaluate the efficacy of processing-independent analysis (PIA) as a novel diagnostic tool for hormone gene expression in tumors.

Main Methods:

• Elucidation of gene, mRNA, and prohormone structures.
• Accumulation of information on prohormone processing enzymes.
• Development and application of processing-independent analysis (PIA) for tumor peptide quantitation.

Main Results:

• Prohormones undergo multiple modifications, including proteolytic cleavages and amino acid derivatizations, during transport.
• Cell-specific processing of prohormones can lead to different bioactive peptides from the same precursor.
• Tumor peptide hormone expression and processing are often attenuated, resulting in clinically silent expression.

Conclusions:

• Understanding cell-specific prohormone processing is crucial for diagnosing peptide-producing tumors, including neuroendocrine neoplasias and carcinomas.
• Processing-independent analysis (PIA) shows diagnostic superiority in quantifying hormone gene expression at the peptide level, irrespective of processing.
• PIA offers a promising new method for accurate tumor diagnosis and understanding peptide synthesis.